Home About us Contact
|
Home About us Contact | ||
|
|
||
Vitamin C Deficiency (vitamin + c_deficiency)
Selected AbstractsRole of Marginal Vitamin C Deficiency in Atherogenesis: In Vivo Models and Clinical StudiesBASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 6 2009Henriette Frikke-Schmidt Naturally, vitamin C has been the subject of many investigations over the past decades in relation to its possible beneficial effects on cardiovascular disease primarily based on its powerful yet general antioxidant properties. However, growing epidemiological, clinical and experimental evidence now suggests a more specific role of ascorbate in vasomotion and in the prevention of atherosclerosis. For example, in contrast to most other biological antioxidants, administration of vitamin C can apparently induce vasodilation. Millions of people worldwide can be diagnosed with vitamin C deficiency according to accepted definitions. In this perspective, the present review examines the evidence for a specific link between vitamin C deficiency and increased risk of atherosclerosis as well as the possible mechanisms by which vitamin C may exert its protective function. [source] Determinants and adequacy of food consumption of children in La Trinidad, the PhilippinesINTERNATIONAL JOURNAL OF CONSUMER STUDIES, Issue 3 2007Nienke Blijham Abstract In the Philippines, vitamin A and vitamin C deficiencies, particularly among children, is a pressing health problem. This article reports the results of a research project that aimed at gaining insight into the factors in the household context that influence food intake of children and the role these factors play in vitamin A and vitamin C deficiencies. The research was carried out in La Trinidad, an urban area in the Philippines, where sufficient nutritious foods proved to be available. The results show that household income has only a minor impact on nutritional status. The nutritional status of children seems to be primarily influenced by their food preferences and the level of parental control on their food intake. [source] Roles of lipid-soluble vitamins during ontogeny of marine fish larvaeAQUACULTURE RESEARCH, Issue 5 2010Kristin Hamre Abstract The roles of lipid-soluble vitamins during ontogeny of marine fish larvae are a subject topic where only fragments of the whole picture are known. Most of the research has been focussed on the larval requirements and the availability of these vitamins in the live feed organisms used for early-stage larvae, while the function of the vitamins in the larvae themselves is largely unknown. Our knowledge is mostly extrapolated from research on other vertebrates and also in part from juvenile and adult fish. Vitamin A is known to be essential for establishing body and organ axes in vertebrate embryos and interacts with other nutrients such as vitamin D and fatty acids through the steroid/thyroid nuclear hormone receptor family. In marine fish larvae, excess vitamin A stimulates pigmentation, but at the same time induces vertebral deformities. Live feed organisms contain very little vitamin A but marine fish larvae appear to convert carotenoids in Artemia and copepods to vitamin A, while rotifers, which contain little carotenoids, should be enriched with vitamin A. Vitamin E acts as an antioxidant and is important for the protection of marine fish larvae against the oxidation pressure probably present in intensive rearing systems. Vitamin E may also have other roles connected to its modulation of cell and tissue red-ox balance. In marine fish larvae and juveniles, vitamin E has been shown to enhance the symptoms of vitamin C deficiency, while protecting against the oxidative effect of n-3 fatty acids. Vitamin D is important for the modulation of calcium and phosphorus homeostasis and for the development of the vertebrate skeleton. Vitamin K influences bone development and coagulation of the blood. There is little information on vitamins D and K connected to the ontogeny of marine fish larvae. [source] Role of Marginal Vitamin C Deficiency in Atherogenesis: In Vivo Models and Clinical StudiesBASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 6 2009Henriette Frikke-Schmidt Naturally, vitamin C has been the subject of many investigations over the past decades in relation to its possible beneficial effects on cardiovascular disease primarily based on its powerful yet general antioxidant properties. However, growing epidemiological, clinical and experimental evidence now suggests a more specific role of ascorbate in vasomotion and in the prevention of atherosclerosis. For example, in contrast to most other biological antioxidants, administration of vitamin C can apparently induce vasodilation. Millions of people worldwide can be diagnosed with vitamin C deficiency according to accepted definitions. In this perspective, the present review examines the evidence for a specific link between vitamin C deficiency and increased risk of atherosclerosis as well as the possible mechanisms by which vitamin C may exert its protective function. [source] Acute scurvy during treatment with interleukin-2CLINICAL & EXPERIMENTAL DERMATOLOGY, Issue 7 2009D. T. Alexandrescu Summary The association of vitamin C deficiency with nutritional factors is commonly recognized. However, an acute form of scurvy can occur in patients with an acute systemic inflammatory response, which is produced by sepsis, medications, cancer or acute inflammation. The frequency of acute hypovitaminosis C in hospitalized patients is higher than previously recognized. We report the occurrence of acute signs and symptoms of scurvy (perifollicular petechiae, erythema, gingivitis and bleeding) in a patient hospitalized for treatment of metastatic renal-cell carcinoma with high-dose interleukin-2. Concomitantly, serum vitamin C levels decreased to below normal. Better diets and longer lifespan may result a lower frequency of acute scurvy and a higher frequency of scurvy associated with systemic inflammatory responses. Therefore, increased awareness of this condition can lead to early recognition of the cutaneous signs of acute scurvy in hospitalized patients with acute illnesses or in receipt of biological agents, and prevent subsequent morbidity such as bleeding, anaemia, impaired immune defences, oedema or neurological symptoms. [source] | ||||||||||